As of the latest Form 4 filed Jul 10, 2026.
What Evommune, Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
2 different Evommune, Inc. insiders made open-market purchases in the last 30 days. When several insiders buy at once it’s a stronger, harder-to-explain-away signal than a single trade — how to read this.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 17 most recent filings for EVMN.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 2026-07-08 | Carver Kyle Chief Financial Officer | PPurchase | +1.00K | $13.26 | $13.3K | No | Form 4 ↗ |
| 2026-07-08 | 2026-07-07 | KIRSCH ARTHUR S Director | PPurchase | +10.0K | $13.30 | $133K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Patel Jeegar Pravinkumar Chief Scientific Officer | SSale | −1.49K | $22.50 | $33.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Patel Jeegar Pravinkumar, Chief Scientific Officer | MExercise | +1.49K | $3.84 | $5.71K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Drew Janice Suzann Chief of Dev. Operations | SSale | −20.0K | $22.63 | $453K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Drew Janice Suzann, Chief of Dev. Operations | MExercise | +16.2K | $2.99 | $48.3K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Drew Janice Suzann, Chief of Dev. Operations | MExercise | +3.84K | $3.84 | $14.7K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Pena Luis C. President & CEO | SSale | −7.44K | $22.71 | $169K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-02 | Cohen David E Director | SSale | −600.00 | $21.38 | $12.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-02 | Cohen David E, Director | SSale | −5.46K | $20.21 | $110K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Patel Jeegar Pravinkumar Chief Scientific Officer | SSale | −16.7K | $22.74 | $379K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Patel Jeegar Pravinkumar, Chief Scientific Officer | MExercise | +13.5K | $3.84 | $51.9K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Pena Luis C. President & CEO | SSale | −16.8K | $22.74 | $382K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Carver Kyle Chief Financial Officer | SSale | −18.2K | $22.84 | $415K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Carver Kyle, Chief Financial Officer | MExercise | +15.0K | $2.99 | $44.9K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Moss Gregory S. Chief Business & Legal Officer | SSale | −14.2K | $22.83 | $325K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Moss Gregory S., Chief Business & Legal Officer | MExercise | +14.2K | $1.71 | $24.3K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also EVMN’s full analysis or the market-wide insider trading feed. The tabs above jump to EVMN’s other SEC data.
Source: SEC Form 4 filings for EVMN, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.